Phosphatidylserine vs TUDCA (Tauroursodeoxycholic Acid)

Mechanism

Major phospholipid component of neuronal cell membranes (15-20% of total phospholipid pool) that maintains membrane fluidity and supports signal transduction. Serves as a cofactor for protein kinase C (PKC), Na+/K+-ATPase, and other membrane-bound enzymes critical for neurotransmitter release. Blunts HPA axis hyperactivation by modulating corticotrophin-releasing factor (CRF) receptor interactions, attenuating cortisol release during physical and psychological stress. Facilitates acetylcholine, dopamine, and norepinephrine release, and enhances glucose metabolism in the brain.

Standard Dosing

100-300mg daily

Timing

With meals (fat-containing preferred for absorption). Can be taken morning or evening. Cortisol-blunting effects are relevant for evening/pre-bed dosing in stressed individuals.

Cycle Duration

Ongoing; no cycling required. Clinical benefits observed from 6-12 weeks.

Side Effects

• Mild GI upset at high doses
• Insomnia (if taken too late in some individuals)
• Rare: nausea
• GI distress (uncommon)
• Insomnia (at higher doses)
• Headache (rare)

Contraindications

• Soy allergy (if soy-derived — use sunflower-derived instead)
• Known soy allergy (soy-derived PS)
• Antiphospholipid syndrome (theoretical concern)

Best Stacking Partners

Mechanism

TUDCA is a water-soluble bile acid conjugate (taurine + ursodeoxycholic acid) with potent hepatoprotective and cytoprotective properties. It inhibits the mitochondrial pathway of apoptosis by preventing BAX translocation to mitochondria and cytochrome c release. TUDCA reduces endoplasmic reticulum (ER) stress by acting as a chemical chaperone, assisting protein folding and reducing the unfolded protein response (UPR). It protects hepatocytes by stabilizing cell membranes, displacing toxic hydrophobic bile acids (chenodeoxycholic, lithocholic) from biliary epithelium, and promoting choleresis (bile flow). Additionally, it has neuroprotective effects via reduction of ER stress in neurons and modulation of the TGR5 bile acid receptor.

Standard Dosing

250-500mg daily

Timing

With meals for liver support. Some protocols recommend before meals to prime bile flow.

Cycle Duration

Cycle 4-8 weeks for liver support; ongoing at low dose for chronic liver conditions under supervision

Side Effects

• Diarrhea (dose-dependent)
• GI discomfort
• Flatulence
• Rare: calcification of gallstones

Contraindications

• Complete biliary obstruction (cannot reach bile ducts if obstruction is complete)
• Calcified gallstones (UDCA/TUDCA dissolve cholesterol stones, not calcified)
• Acute cholangitis
• Complete biliary obstruction
• Gallstones (may mobilize stones)

Best Stacking Partners